NCATS Inxight Drugs: a comprehensive and curated portal for translational research.

ABSTRACT: The United States has a complex regulatory scheme for marketing drugs. Understanding drug regulatory status is a daunting task that requires integrating data from many sources from the United States Food and Drug Administration (FDA), US government publications, and other processes related to drug development. At NCATS, we created Inxight Drugs (https://drugs.ncats.io), a web resource that attempts to address this challenge in a systematic manner. NCATS Inxight Drugs incorporates and unifies a wealth of data, including those supplied by the FDA and from independent public sources. The database offers a substantial amount of manually curated literature data unavailable from other sources. Currently, the database contains 125 036 product ingredients, including 2566 US approved drugs, 6242 ma

SUBMITTER: Siramshetty VB 

PROVIDER: S-EPMC8728186 | biostudies-literature | 2022 Jan

REPOSITORIES: biostudies-literature